| Literature DB >> 29642875 |
Collins Okoyo1, Elses Simiyu2, Sammy M Njenga2, Charles Mwandawiro2.
Abstract
BACKGROUND: Kato-Katz technique has been the mainstay test in Schistosoma mansoni diagnosis in endemic areas. However, recent studies have documented its poor sensitivity in evaluating Schistosoma mansoni infection especially in areas with lower rates of transmission. It's the primary diagnostic tool in monitoring impact of the Kenya national school based deworming program on infection transmission, but there is need to consider a more sensitive technique as the prevalence reduces. Therefore, this study explored the relationship between results of the stool-based Kato-Katz technique with urine-based point-of-care circulating cathodic antigen (POC-CCA) test in view to inform decision-making by the program in changing from Kato-Katz to POC-CCA test.Entities:
Keywords: Circulating cathodic antigen; Kato-Katz; Schistosoma mansoni
Mesh:
Substances:
Year: 2018 PMID: 29642875 PMCID: PMC5896080 DOI: 10.1186/s12889-018-5414-9
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Number of schools and children examined by county
| County | Pre-treatment | Post-treatment | ||
|---|---|---|---|---|
| Number of schools | Number of children | Number of schools | Number of children | |
| Bomet | 1 | 108 | 1 | 103 |
| Bungoma | 1 | 108 | 1 | 105 |
| Busia | 2 | 214 | 2 | 210 |
| Homa Bay | 1 | 108 | 1 | 102 |
| Kakamega | 2 | 212 | 2 | 213 |
| Kisii | 1 | 105 | 1 | 103 |
| Kisumu | 3 | 312 | 3 | 313 |
| Kwale | 3 | 317 | 3 | 316 |
| Mombasa | 1 | 98 | 1 | 108 |
| Narok | 2 | 215 | 2 | 214 |
| Taita Taveta | 1 | 102 | 1 | 91 |
| Overall | 18 | 1899 | 18 | 1878 |
Comparison of S. mansoni prevalence (%) using POC-CCA and Kato-Katz techniques among school aged children
| County | Kato Katz | POC-CCA | Kappa statistics (Agreement %) | ||||
|---|---|---|---|---|---|---|---|
| Pre-treatment (%) | Post-treatment (%) | RR (%) | Pre-treatment (%) | Post-treatment (%) | RR (%) | ||
| Overall | 4.9 (4.0–5.9) | 1.5 (1.0–2.1) | 69.8 | 26.5 (24.6–28.6) | 21.4 (19.6–23.4) | 19.4 | 0.11 (77.1%) |
| Bomet | 0 | 0 | 0 | 61.9 (53.3–71.9) | 54.9 (46.0–65.5) | 11.3 | 0.00 (42.1%) |
| Bungoma | 0 | 2.0 (0.5–7.7) | + | 8.6 (4.6–16.0) | 14.6 (9.1–23.2) | + | 0.06 (88.8%) |
| Busia | 28.7 (23.2–35.5) | 2.9 (1.3–6.4) | 89.9* | 46.6 (40.3–53.9) | 23.3 (18.2–29.9) | 50.0* | 0.28 (71.4%) |
| Homa Bay | 0 | 3.0 (1.0–9.1) | + | 8.3 (4.5–15.6) | 13.9 (8.5–22.5) | + | 0.13 (89.3%) |
| Kakamega | 1.9 (0.7–5.0) | 5.8 (3.3–10.0) | + | 20.2 (15.4–26.5) | 36.8 (30.8–44.0) | + | 0.12 (73.4%) |
| Kisii | 0 | 0 | 0 | 12.1 (7.1–20.6) | 15.0 (9.4–23.9) | + | 0.00 (86.1%) |
| Kisumu | 7.1 (4.7–10.6) | 1.3 (0.5–3.5) | 81.4* | 34.3 (29.4–40.1) | 14.1 (10.7–18.6) | 58.9* | 0.15 (77.4%) |
| Kwale | 0 | 0 | 0 | 6.6 (4.3–10.2) | 8.5 (5.9–12.3) | + | 0.00 (92.5%) |
| Mombasa | 1.9 (0.3–13.4) | 0 | 100 | 9.7 (5.2–18.0) | 5.6 (2.6–12.2) | 42.1 | −0.01 (90.3%) |
| Narok | 0.9 (0.2–3.7) | 0 | 100 | 47.4 (41.1–54.6) | 42.9 (36.7–50.1) | 9.5 | 0.01 (55.2%) |
| Taita Taveta | 0 | 0 | 0 | 19.2 (12.8–28.8) | 2.4 (0.6–9.3) | 87.7 | 0.00 (88.5%) |
RR indicates relative reduction in prevalence
+indicates an increase in prevalence rather than reduction
*indicates a significant relative reduction in prevalence, p < 0.05
Comparative evaluation of the POC-CCA and the Kato-Katz parasitological examination for the diagnosis of S. mansoni infection
| Diagnostic technique | Kato-Katz stool examination | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pre-treatment | Post-treatment | Overall | ||||||||
| Positive | Negative | Total | Positive | Negative | Total | Positive | Negative | Total | ||
| POC-CCA urine examination | Positive | 60 | 419 | 479 | 20 | 363 | 383 | 80 | 782 | 862 |
| Negative | 27 | 1255 | 1282 | 7 | 1409 | 1416 | 34 | 2664 | 2698 | |
| Total | 87 | 1674 | 1761 | 27 | 1772 | 1799 | 114 | 3446 | 3560 | |
Showing the performance measures of Kato-Katz by each survey round with POC-CCA as the gold standard
| Treatment round | Sensitivity %(95% CI) | Specificity %(95% CI) | LR+ %(95% CI) | LR− %(95% CI) | PPV %(95% CI) | NPV %(95% CI) | Kappa index (Agreement %) |
|---|---|---|---|---|---|---|---|
| Pre-treatment | 12.5 (9.7–15.8) | 97.9 (97.0–98.6) | 6.0 (3.8–9.3) | 0.9 (0.9–0.9) | 69.0 (58.1–78.5) | 75.0 (72.8–77.0) | 0.14 (74.7%) |
| Post-treatment | 5.2 (3.2–7.9) | 99.5 (99.0–99.8) | 10.6 (4.5–24.8) | 1.0 (0.9–1.0) | 74.1 (53.7–88.9) | 79.5 (77.6–81.4) | 0.07 (79.4%) |
| Overall | 9.3 (7.4–11.4) | 98.7 (98.2–99.1) | 7.4 (5.0–10.92) | 0.9 (0.9–0.9) | 70.2 (60.9–78.4) | 77.3 (75.9–78.7) | 0.11 (77.1%) |
PPV positive predictive value, NPV negative predictive value, LR positive likelihood ratio, LR negative likelihood ratio
**Obtained from McNemar’s chi-square (Χ2m) test (sensitivity & specificity) / Weighted generalized score chi-square test (PPV & NPV)